TERT and neoplasm: The recurrent mutually exclusive C > T somatic mutations in the TERT promoter at –124 (1,295,228) bp and –146 (1,295,250) bp, like familial mutation, result in the creation of a binding motif for the ETS (E26 transformation-specific) transcription factors with consequent tumor-specific increased TERT expression (Figure 1).